Cencora Inc(COR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 6:10 PM ET (Korea 9/12 07:10)
Full metrics table
| Index | S&P 500 | P/E | 23.91 | EPS (ttm) | 13.45 | Insider Own | 0.49% | Shs Outstand | 190.8M | Perf Week | -4.64% |
| Market Cap | 61.36B | Forward P/E | 16.23 | EPS next Y | 10.83% | Insider Trans | -0.4% | Shs Float | 189.9M | Perf Month | 2.36% |
| Enterprise Value | 70.41B | PEG | 1.46 | EPS next Q | 4.57 | Inst Own | 100% | Short Float | 2.38% | Perf Quarter | 14.24% |
| Income | 2.62B | P/S | 0.18 | EPS this Y | 11.72% | Inst Trans | -1.56% | Short Ratio | 3.09 | Perf Half Y | -8.81% |
| Sales | 332.77B | P/B | 20.11 | EPS next 5Y | 11.09% | ROA | 3.33% | Short Interest | 4.53M | Perf YTD | -4.79% |
| Book/sh | 15.99 | P/C | 21.42 | EPS past 3/5Y | -0.34% - | ROE | 104.34% | 52W High | -14.82% ($377.54) | Perf Year | 6.2% |
| Cash/sh | 15.01 | P/FCF | 15.11 | Sales past 3/5Y | 10.43% 11.09% | ROIC | 18.11% | 52W Low | 31.35% ($244.82) | Perf 3Y | 80.93% |
| Dividend Est. | $2.39 (0.74%) | EV/EBITDA | 12.9 | EPS Y/Y TTM | 38.1% | Gross Margin | 3.62% | Volatility(W/M) | 1.76% 2.11% | Perf 5Y | 161.84% |
| Dividend TTM | 2.4 | EV/Sales | 0.21 | Sales Y/Y TTM | 5.09% | Oper. Margin | 1.32% | ATR (14) | 7.32 | Perf 10Y | 276.94% |
| Dividend Ex-Date | 2026/8/14 | Quick Ratio | 0.58 | EPS Q/Q | 11.81% | Profit Margin | 0.79% | RSI (14) | 50.26 | Recom | 1.84 |
| Dividend Gr. 3/5Y | 6.14% 5.79% | Current Ratio | 0.93 | Sales Q/Q | 5.07% | SMA20 | -0.52% ($323.25) | Beta | 0.57 | Target Price | $368.92 |
| Payout | 27.63% | Debt/Eq | 3.84 | Earnings | 2026/8/5 | SMA50 | 2.04% ($315.14) | Rel Volume | 0.57 | Prev Close | $320.95 |
| Employees | 51000 | LT Debt/Eq | 3.75 | EPS/Sales Surpr. | 3.07% 0.52% | SMA200 | 0.14% ($321.12) | Avg Volume(3M) | 1.47M | Price | $321.57 |
| IPO | 1995/4/4 | Option/Short | Yes/Yes | Trades | 14772 | Volume | 832,085 | Change | 0.19% |
Company
COR is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A major U.S.-headquartered pharmaceutical distribution company that combines global pharmaceutical wholesale and distribution with specialty pharmaceuticals, animal health products, and healthcare solutions. The company changed its name from the former AmerisourceBergen and is one of the Big 3 in the U.S. pharmaceutical wholesale category.
Over the past 1 year, roughly in the middle
15% below its 1-year high.
COR has weak earning power
Review management risk carefully before investing
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.7% this year.
Tap to view numbers
The price looks about right
Trading at 23.9 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +80.9% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.74% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 100.0%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
CWS 0.03%
PPH 0.03%
STNC 0.03%
JMID 0.03%
TMED 0.03%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
VCIT 68.5B
BSV 46.3B
VCSH 44.6B
USHY 28.1B
LQD 28.1BIt ranks #2 in the industry
Based on market cap of $61B.
COR $61B PER 23.9
MCK $103B PER 23.6
CAH $55B PER 32.4
HSIC $10B PER 25.8
실적분석 · 8/5 Cencora ($COR) Q3 FY2026 Earnings Analysis — Adjusted EPS and Revenue Both Beat, Full-Year Guidance Raised 투자 가이드 · 4/11 The Complete 2026 Guide to U.S. Dividend Aristocrats 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is COR?
COR belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of COR?
The market cap of COR is approximately $61.4B, ranking 276 within its sector.
Does COR pay dividends?
COR has a dividend yield of approximately 0.74%, with an annual dividend of $2.39.
What is the P/E ratio of COR?
COR has a P/E ratio of approximately 23.9x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for COR?
COR has recorded a 52-week high of $377.54 and a low of $244.82.
